Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by nozzpackon Aug 24, 2021 8:26am

264 Views

Post# 33753731

Peer Based Price to Book

The current value is 6.7 times book..see link below.

Current Book value is $47 million cad.

At current Price to book valuation multiupole of 6.7 , the fair market cap valuation is $315 million CAD.

Once again, we see a fair value ( $11.60 cad ) above $10 per share.

Very undervalued and a very good takeover candidate

https://csimarket.com/Industry/industry_valuation_ttm.php?pb&ind=803

<< Previous

Bullboard Posts

Next >>

This profitable gold stock is on its way up